STOCK TITAN

GE HealthCare (GEHC) executive Catherine Estrampes details stock and option stakes

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. executive Catherine Estrampes, Chief Commercial & Growth Officer, reports beneficial ownership of 24,081 shares of common stock. This includes 14,374 shares plus restricted stock units that may settle into additional shares as they vest.

She also holds multiple employee stock options on GE HealthCare common stock. These options cover underlying share amounts such as 16,398 shares at an exercise price of $80.16 expiring on March 2, 2036, and 9,923 shares at $86.45 expiring on March 3, 2035, along with several other grants with different prices and expirations.

Positive

  • None.

Negative

  • None.
Insider Estrampes Catherine
Role Chief Commer. & Growth Officer
Type Security Shares Price Value
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Employee Stock Option (right to buy) -- -- --
holding Common Stock, par value $0.01 per share -- -- --
Holdings After Transaction: Employee Stock Option (right to buy) — 70,703 shares (Direct); Common Stock, par value $0.01 per share — 24,081 shares (Direct)
Footnotes (8)
  1. F1. Consists of (i) 14,374 shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock; (ii) 3,470 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028; and (iii) 6,237 restricted stock units with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
  2. F2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
  3. F3. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the distribution of shares of GE HealthCare common stock by GE to holders of GE common stock on a pro rata basis, 100% of which is currently exercisable.
  4. F4. Award of an employee stock option with respect to GE HealthCare common stock, granted on February 1, 2023, of which 100% is currently exercisable.
  5. F5. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2023, of which 100% is currently exercisable.
  6. F6. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2024, of which 100% is currently exercisable.
  7. F7. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028.
  8. F8. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
Common shares owned 24,081 shares Total beneficial ownership of GE HealthCare common stock
Direct common shares 14,374 shares Portion of total common stock held directly
RSUs grant 2025 3,470 units Restricted stock units granted March 3, 2025
RSUs grant 2026 6,237 units Restricted stock units granted March 2, 2026
Option position A 16,398 shares at $80.16 Employee stock option, expiration March 2, 2036
Option position B 9,923 shares at $86.45 Employee stock option, expiration March 3, 2035
Option position C 8,052 shares at $92.72 Employee stock option, expiration March 1, 2034
Option position D 14,109 shares at $70.01 Employee stock option, expiration February 1, 2033
restricted stock units financial
"3,470 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
employee stock option financial
"Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
equity incentive awards financial
"conversion of certain equity incentive awards previously granted by General Electric Company"
Equity incentive awards are company grants that pay employees or directors with a stake in the business—typically stock, stock options, or restricted shares—rather than only cash. They matter to investors because they align employees’ interests with shareholders (like giving team members slices of the same pie to encourage growth) but can also increase the total number of shares outstanding, which can reduce each existing shareholder’s percentage ownership and impact reported profits.
beneficial ownership financial
"reports beneficial ownership of 24,081 shares of GE HealthCare common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
exercise price financial
"exercisePrice: "80.1600" and other listed exercise prices for employee stock options"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

How many GEHC shares does Catherine Estrampes report owning on Form 3?

Catherine Estrampes reports beneficial ownership of 24,081 GE HealthCare common shares. This figure combines 14,374 directly held shares and 9,707 restricted stock units that may convert into additional shares as they vest over scheduled future dates.

What restricted stock units does GEHC officer Catherine Estrampes hold?

She holds 3,470 restricted stock units granted on March 3, 2025 and 6,237 restricted stock units granted on March 2, 2026. Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement, subject to vesting.

What stock options are reported for Catherine Estrampes in GEHC Form 3?

The filing lists several employee stock options on GE HealthCare common stock. Examples include options over 16,398 underlying shares at an exercise price of $80.16 expiring March 2, 2036, and 9,923 underlying shares at $86.45 expiring March 3, 2035.

When do Catherine Estrampes’ GEHC restricted stock units vest?

For the 3,470 restricted stock units granted March 3, 2025, vesting is scheduled 33% on September 3, 2026, 33% on September 3, 2027, and 34% on September 3, 2028. The 6,237 units granted March 2, 2026 vest on similar yearly September dates.

Are Catherine Estrampes’ GEHC employee stock options currently exercisable?

Some options are 100% currently exercisable, while others become exercisable over time. Footnotes state certain grants, including awards converted from General Electric Company equity incentives, are fully exercisable, and later grants begin vesting on specified September dates between 2026 and 2029.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Estrampes Catherine

(Last)(First)(Middle)
500 W. MONROE STREET

(Street)
CHICAGO ILLINOIS 60661

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/29/2026
3. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commer. & Growth Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.01 per share24,081(1)(2)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) (3)09/30/2026Common Stock, par value $0.01 per share3,030$161.3D
Employee Stock Option (right to buy) (3)11/17/2027Common Stock, par value $0.01 per share1,606$99.21D
Employee Stock Option (right to buy) (3)03/19/2028Common Stock, par value $0.01 per share4,657$76.66D
Employee Stock Option (right to buy) (3)03/19/2028Common Stock, par value $0.01 per share4,592$76.66D
Employee Stock Option (right to buy) (4)02/01/2033Common Stock, par value $0.01 per share14,109$70.01D
Employee Stock Option (right to buy) (5)03/01/2033Common Stock, par value $0.01 per share8,336$75.3D
Employee Stock Option (right to buy) (6)03/01/2034Common Stock, par value $0.01 per share8,052$92.72D
Employee Stock Option (right to buy) (7)03/03/2035Common Stock, par value $0.01 per share9,923$86.45D
Employee Stock Option (right to buy) (8)03/02/2036Common Stock, par value $0.01 per share16,398$80.16D
Explanation of Responses:
1. Consists of (i) 14,374 shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock; (ii) 3,470 restricted stock units with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028; and (iii) 6,237 restricted stock units with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
3. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the distribution of shares of GE HealthCare common stock by GE to holders of GE common stock on a pro rata basis, 100% of which is currently exercisable.
4. Award of an employee stock option with respect to GE HealthCare common stock, granted on February 1, 2023, of which 100% is currently exercisable.
5. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2023, of which 100% is currently exercisable.
6. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 1, 2024, of which 100% is currently exercisable.
7. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 3, 2025, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028.
8. Award of an employee stock option with respect to GE HealthCare common stock, granted on March 2, 2026, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)